Bismuth Subsalicylate recalls
The FDA has published 2 recalls involving Bismuth Subsalicylate since 2014. The latest was reported on 17 Apr 2019. Most were for labeling errors. Lohxa has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 17 Apr 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why bismuth subsalicylate is recalled
Companies
By year
All bismuth subsalicylate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bismuth Subsalicylate Oral Suspension 262mg/, unit dose cups recalled | Lohxa | Other | MA, NY, WY |
| Drug | CLASS II | Bismuth Subsalicylate, Chew Tablet, 262 mg, Over The Counter recalled | Aidapak Services | Labeling Errors | 4 states |
Should you stop taking Bismuth Subsalicylate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.